Second Sight Reports Second Quarter 2019 Financial Results
LOS ANGELES--(BUSINESS WIRE)--Second Sight Medical Products, Inc. (NASDAQ: EYES) (“Second Sight” or the “Company”), a developer, manufacturer and marketer of implantable visual prosthetics that are intended to create an artificial form of useful vision for blind individuals, today reported financial results for the three- and six-months ended June 30, 2019. Recent Financial and Corporate Highlights: Continued progress on development of the Orion® Visual Cortical Prosthesis System (“Orion”); Met